Bio Special BioInvest
NewVale Capital leads $14 Million Series B growth round Industry leading executive, Rick Riegel, joins as Chairman of the Board Newly formed Strategic ...
June 14, 2023 | News
Eccogene Inc., a clinical-stage biotechnology company developing innovative therapeutic solutions for metabolic diseases, announced a CNY 1...
June 12, 2023 | News
Proteologix to receive in-kind products and services to develop treatments for autoimmune/inflammatory diseases and oncology indications Experts from Me...
June 07, 2023 | News
Series D led by Digital Mobile Venture with participation from additional existing investors Funds will support expansion and progress of oncology pipelin...
June 07, 2023 | News
Under an exclusive licensing agreement, Amplo Biotechnology has gained access to AAV-ColQ data developed by Professor Kinji Ohno's laboratory at&...
May 30, 2023 | News
Highlights: Revenue of $1.72 billion represents 6.8% reported growth year-over-year; and up 9.5% on a core(1) basis. GAAP net income of $302...
May 24, 2023 | News
TVM Capital Healthcare, a global specialist healthcare private equity firm headquartered in Dubai and Singapore, is pleased to announce an i...
May 23, 2023 | News
Financial results of Q1 2023 Group net sales rise by 1.8% to € 5.3 billion New Healthcare products major growth drivers EBITDA pre...
May 18, 2023 | News
With more than 80% of its rapidly growing revenues tied to large molecule applications, Wyatt accelerates Waters' ability to build a high-growth business i...
May 17, 2023 | News
Establishing this local office comes after TVM Capital Healthcare successfully expanded its portfolio company Cambridge Medical and Rehabilitation Center f...
May 16, 2023 | News
MRA-funded research spans the entire spectrum of the disease including melanoma prevention, diagnosis, treatment, and metastatic disease. Melanoma is the d...
May 02, 2023 | News
CBC Group ("CBC"), Asia's largest healthcare-dedicated investment firm headquartered in Singapore, and Hasten Biopharmaceutic Company Limite...
April 20, 2023 | News
Staffed with a team of highly skilled research, application and formulation experts, the new $25 million center will be an advanced training and coll...
April 20, 2023 | News
Revenue of the Group for the year ended December 31, 2022 was approximately US$625.7 million, representing an increase of 27.7% as compare...
March 31, 2023 | Company results
Most Read
Bio Jobs
News